Gabay Avraham Insider Trades & Stock Holdings

Chief Financial Officer · Oramed Pharmaceuticals Inc. · Latest filing Oct 1, 2026

Gabay Avraham, Chief Financial Officer at Oramed Pharmaceuticals Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($90.20K), net -$90.20K. Latest filing: disposed of 20K shares of $ORMP on Oct 1, 2026 at $4.51.

Trades on file

1

Open-market bought

$0

Open-market sold

$90.20K

Net open-market

-$90.20K

Latest filing

Oct 1, 2026

All insider trades by Gabay Avraham

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$ORMP	Sell (Open-market sale) 10b5-1	20K	$4.51	$90.20K						Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Gabay Avraham traded

• $ORMP

Frequently asked questions

Has Gabay Avraham been buying or selling stock?

Gabay Avraham has 0 open-market purchases and 1 open-market sale on file, net -$90.20K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Gabay Avraham's latest insider trade?

disposed of 20K shares of $ORMP on Oct 1, 2026 at $4.51.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.